In Norway, a Vision of Industrial Renewal Goes Unfinished

Norway's Ambition Blanketed in Gray

The Arctic city of Mo i Rana in Norway, was once a stronghold of hydroelectric power and steel production, offering tantalizing visions of a rebirth as a clean industry hub. But the completion of the mammoth battery factory Freyr stands as an unfulfilled dream, a symbol of the uncertainties that accompany the global push to decarbonize.

When the Biden administration's sweeping climate bill passed in 2022, it included a tantalizing incentive: tax credits for the manufacture of electric vehicle batteries in the United States. For a brief moment, it seemed like a breakthrough for Freyr — until it became clear that the company wouldn't meet the eligibility criteria.

A Dream Undone by Distance

Freyr's story begins in 2020, when a group of renewable energy executives conceived of a plan to capture Norway's abundant resources to produce batteries for electric vehicles. The company secured $242 million in funding, with the vision of building a giant factory in Mo i Rana, nestled on the Arctic coast. The location was ideal: The city, nicknamed "The Battery Town," already hosted several large-scale renewable energy facilities.

By 2021, construction was underway on what would have been one of the world's largest battery factories, with an estimated price tag of around $2.8 billion. But the company still needed more funding to reach completion — and that's when the Inflation Reduction Act (IRA) was passed, including the critical provision that incentivized domestic battery manufacturing.

A Tenuous Future

But as Freyr looked to raise the capital needed to finish the factory, it faced a significant hurdle: to qualify for the IRA tax credits, a battery manufacturer would need to demonstrate that it would be producing a commercial-grade battery by the end of 2024. Despite having begun construction, Freyr had never produced a battery. And while the company secured a supply agreement with Tesla in May 2023, it's still awaiting official qualification for the tax credits.

The company has struggled to raise funds, with investors wary of the competition and the manufacturing challenges faced by an unproven player in the industry.

As the Arctic polar night begins, the future of the Mo i Rana factory remains uncertain, a haunting testament to the fine line walked by governments and businesses in the global quest for decarbonization.

While the town waits for its uncertain future, heavy snowflakes fall on the hulking concrete shell, an unfinished testament to unfulfilled economic hope.

Read more

Prospective observational study of peripheral intravenous cannula utilisation and frequency of intravenous fluid delivery in the emergency department: convenience or necessity?

Introduction Over one billion peripheral intravenous cannulas (PIVCs) are inserted worldwide each year. Insertion of PIVCs is associated with pain, phlebitis, occlusion, and medication extravasation as well as the risk of catheter-associated infection, with an associated cost to departmental resources. Previous studies have not assessed if intravenous (IV) fluid delivery